Rethinking Clinical Trial Operations with AI and Remote Monitoring - with Scott Bradley of Novartis

Summary

The post highlights a podcast episode with Scott Bradley, Novartis’ VP of AI and Innovation, discussing how artificial intelligence and remote monitoring are reshaping clinical trial design, operations, and patient engagement. Key takeaways include AI‑driven trial optimization, real‑time data collection via remote sensors, faster timelines, and enhanced trust and accountability across the industry. The author presents these insights through an interview format aimed at non‑technical business leaders, emphasizing practical AI adoption for measurable ROI.